Reproductive Phenotypes and Genotypes in Men With IHH.

J Clin Endocrinol Metab

Massachusetts General Hospital-Harvard Center for Reproductive Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Published: March 2023

AI Article Synopsis

  • The study investigates the relationship between genetic severity and reproductive outcomes in men with isolated hypogonadotropic hypogonadism (IHH).
  • The research involved analyzing olfaction changes, testicular development, and hormone secretion patterns in 242 men over four decades, revealing that those with absent puberty have lower hormone levels and unique genetic profiles.
  • Findings suggest that partial puberty and certain hormone levels can predict hormone secretion patterns, while specific genetic variants, particularly in the ANOS1 gene, are linked to severe reproductive issues in these men.

Article Abstract

Context: Isolated hypogonadotropic hypogonadism (IHH) is phenotypically and genetically heterogeneous.

Objective: This work aimed to determine the correlation between genotypic severity with pubertal and neuroendocrine phenotypes in IHH men.

Methods: A retrospective study was conducted (1980-2020) examining olfaction (Kallmann syndrome [KS] vs normosmic IHH [nHH]), baseline testicular volume (absent vs partial puberty), neuroendocrine profiling (pulsatile vs apulsatile luteinizing hormone [LH] secretion), and genetic variants in 62 IHH-associated genes through exome sequencing (ES).

Results: In total, 242 men (KS: n = 131 [54%], nHH: n = 111 [46%]) were included. Men with absent puberty had significantly lower gonadotropin levels (P < .001) and were more likely to have undetectable LH (P < .001). Logistic regression showed partial puberty as a statistically significant predictor of pulsatile LH secretion (R2 = 0.71, P < .001, OR: 10.8; 95% CI, 3.6-38.6). Serum LH of 2.10 IU/L had a 95% true positive rate for predicting LH pulsatility. Genetic analyses in 204 of 242 IHH men with ES data available revealed 36 of 204 (18%) men carried protein-truncating variants (PTVs) in 12 IHH genes. Men with absent puberty and apulsatile LH were enriched for oligogenic PTVs (P < .001), with variants in ANOS1 being the predominant PTV in this genotype-phenotype association. Men with absent puberty were enriched for ANOS1 PTVs compared to partial puberty counterparts (P = .002). PTVs in other IHH genes imparted more variable reproductive phenotypic severity.

Conclusion: Partial puberty and LH greater than or equal to 2.10 IU/L are proxies for pulsatile LH secretion. ANOS1 PTVs confer severe reproductive phenotypes. Variable phenotypic severity in the face of severe genetic variants in other IHH genes point to significant neuroendocrine plasticity of the HPG axis in IHH men.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211495PMC
http://dx.doi.org/10.1210/clinem/dgac615DOI Listing

Publication Analysis

Top Keywords

partial puberty
16
men absent
12
absent puberty
12
ihh genes
12
ihh
9
reproductive phenotypes
8
men
8
genetic variants
8
pulsatile secretion
8
210 iu/l
8

Similar Publications

Perfluorinated compounds linked to central precocious puberty in girls during COVID-19: an untargeted metabolomics study.

Front Endocrinol (Lausanne)

January 2025

Department of Pediatrics, Hainan Medical University School of Pediatrics, Hainan Women and Children's Medical Center, Haikou, Hainan, China.

Background And Objective: The incidence of central precocious puberty (CPP) in girls increased significantly during the COVID-19 pandemic. This study aimed to explore the impact of perfluorinated endocrine disruptors on CPP through metabolomics analysis in girls from Hainan Province, China.

Methods: Serum samples from 100 girls with CPP and 100 healthy controls were collected.

View Article and Find Full Text PDF

Objective: This study aimed to determine the response to growth hormone (GH) therapy of patients with growth hormone deficiency (GHD), idiopathic short stature (ISS), and small for gestational age (SGA).

Materials And Methods: The data of the 202 children who received GH treatment were analyzed retrospectively. Laboratory parameters, puberty stages, annual growth rates, body mass index (BMI), GH side effects, target height (TH), estimated adult height (EAH), and bone age (BA) were obtained during the GH treatment period.

View Article and Find Full Text PDF

Context: Congenital hypogonadotropic hypogonadism (CHH) is defined as an isolated deficiency of gonadotropin hormones. Mini-puberty, a transient postnatal activation of the hypothalamic-pituitary-gonadal axis in healthy infants, provides a window of opportunity to diagnose and treat CHH. Currently, in male infants with CHH, testosterone is used to increase phallus size.

View Article and Find Full Text PDF

Spermatogenesis starts with the onset of puberty within the seminiferous epithelium of the testes. It is a complex process under intricate control of the endocrine system. Physiological regulations by steroid hormones in general and by estrogens in particular are due to their chemical nature prone to be disrupted by exogenous factors acting as endocrine disruptors (EDs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!